Condition: Bone Metastases · Sponsor: Cardiovascular and Interventional Radiological Society of Europe
BOREALIS is a multicentre, prospective, observational cohort study designed to investigate the effectiveness, feasibility, safety and impact on pain and quality of life of curative-intent cryoablation for the treatment of bone metastases in patients with oligometastatic or bone oligo-progressive disease.
This description comes directly from the study's public registry record.
Claire E Poulet, PhD · +41 79 385 16 78 · borealis@cirse.org
Dhwani S. Korde, PhD · +4367762942469 · borealise@cirse.org
Always discuss trial participation with your own doctor first.
| Institute Bergonié | Bordeaux, France | Recruiting |
| CHRU de Strasbourg | Strasbourg, France | Recruiting |
| Institut Gustave Roussy | Villejuif, France | Recruiting |
| Hospital Universitario y Politécnico La Fe | Valencia, Spain | Recruiting |
| CHUV-Lausanne University Hospital | Lausanne, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06480955